Commodore Capital LP
- SEC CIK
- 0001831942
- Latest filing
- Aug 14, 2026
KPTI holding history
Karyopharm Therapeutics Inc. in every 13F filed by Commodore Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KPTI overviewAll 13F holders of KPTIFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −1,950,000−100.0% | Sold out | Holders |
| Q1 2026 | 1,950,000 | $10.9M | 0.6% | +1,950,000 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −1,935,609−100.0% | Sold out | Holders |
| Q4 2022 | 1,935,609 | $6.58M | 1.0% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,935,609 | $10.6M | 1.7% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,935,609 | $8.73M | 1.8% | −1,625,443−45.6% | Reduced | Holders |
| Q1 2022 | 3,561,052 | $26.2M | 5.9% | +3,561,052 | New | Holders |